Evidence map›Paper›PMID 37271672›Full record

ArticleEuropean urology oncology2024

Re: Derya Tilki, Ming-Hui Chen, Jing Wu, et al. Prostate-specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol 2023;41:2428-35.

Ugo Giovanni Falagario, Alberto Martini, Francesco Pellegrino, Giuseppe Carrieri, Mani Manon, Anna Lantz, Peter Wiklund

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in European urology oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Ugo Giovanni FalagarioDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Urology and Kidney Transplantation, University of Foggia, Foggia, Italy. Electronic address: ugofalagario@gmail.com.
Alberto MartiniDepartment of Urology, MD Anderson Cancer Center, Houston, TX, USA.
Francesco PellegrinoDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Division of Oncology/Unit of Urology, Soldera Prostate Cancer Laboratory, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
Giuseppe CarrieriDepartment of Urology and Kidney Transplantation, University of Foggia, Foggia, Italy.
Mani ManonDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Anna LantzDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA; Departments of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Peter WiklundDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Prostate-Specific AntigenProstatic NeoplasmsHumansMaleProstateProstatectomySalvage TherapyProstate-Specific Antigen

Identifiers

PMID37271672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.